FRA:PFE - Deutsche Boerse Ag - US7170811035 - Common Stock - Currency: EUR
We assign a fundamental rating of 4 out of 10 to PFE. PFE was compared to 50 industry peers in the Pharmaceuticals industry. PFE has a medium profitability rating, but doesn't score so well on its financial health evaluation. PFE has a bad growth rate and is valued cheaply.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.76% | ||
ROE | 9.11% | ||
ROIC | 6.61% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 25.61% | ||
PM (TTM) | 12.62% | ||
GM | 74.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.69 | ||
Debt/FCF | 6.54 | ||
Altman-Z | 1.98 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.17 | ||
Quick Ratio | 0.92 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.36 | ||
Fwd PE | 7.65 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 13.18 | ||
EV/EBITDA | 6.46 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.77% |
FRA:PFE (4/25/2025, 7:00:00 PM)
20.095
+0.05 (+0.27%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 7.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 7.36 | ||
Fwd PE | 7.65 | ||
P/S | 2.04 | ||
P/FCF | 13.18 | ||
P/OCF | 10.17 | ||
P/B | 1.47 | ||
P/tB | N/A | ||
EV/EBITDA | 6.46 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.76% | ||
ROE | 9.11% | ||
ROCE | 9.56% | ||
ROIC | 6.61% | ||
ROICexc | 7.49% | ||
ROICexgc | 39.31% | ||
OM | 25.61% | ||
PM (TTM) | 12.62% | ||
GM | 74.19% | ||
FCFM | 15.46% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.69 | ||
Debt/FCF | 6.54 | ||
Debt/EBITDA | 2.6 | ||
Cap/Depr | 41.48% | ||
Cap/Sales | 4.57% | ||
Interest Coverage | 5.05 | ||
Cash Conversion | 54.68% | ||
Profit Quality | 122.46% | ||
Current Ratio | 1.17 | ||
Quick Ratio | 0.92 | ||
Altman-Z | 1.98 |